Preul Mark C, Campbell Patrick K, Bichard William D, Spetzler Robert F
Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
J Neurosurg. 2007 Sep;107(3):642-50. doi: 10.3171/JNS-07/09/0642.
The authors evaluated whether a polyethylene glycol-based hydrogel sealant system improved dural closures with collagen-based duraplasty onlay grafts.
Dural defects 1.5 cm in diameter were created in 12 canines and repaired with one of two commercially available duraplasty onlay products. In six animals, hydrogel was applied onto the dural onlays, and the other six animals underwent duraplasty only. Before bone flap replacement, watertight closure was assessed. Before the animals were killed, the craniotomy was reopened, adhesions were rated by a neurosurgeon blinded to the treatment groups, and dural integrity was assessed using pressure testing.
The animals that received the hydrogel sealant in addition to the duraplasty withstood intraoperative Valsalva maneuvers up to 20 cm H2O without cerebrospinal fluid (CSF) leakage. The duraplasty-only animals leaked CSF at spontaneous pressures (p = 0.0022). Postoperatively, all six duraplasty-only dogs developed CSF subcutaneous accumulations, compared with only one (16.7%) dog who underwent hydrogel application (p = 0.0152). At the time of harvesting (8 weeks after implantation), duraplasty-only dogs had extensive scarring between the bone flap and the dura mater (median adhesion score 4, range 3-4). The animals receiving hydrogel showed minimal scarring (median adhesion score 0.5, range 0-2). In hydrogel-treated dogs, the mean adhesion score was 82.6% lower than the scores in duraplasty-only animals (p = 0.0043). In animals receiving hydrogel, the mean dural leak pressure was 56.8 +/- 2.5 cm H2O compared with 9.8 +/- 3.8 cm H2O in duraplasty-only dogs (p = 0.0392). Application of the hydrogel was not associated with neurotoxicity, delayed healing, degenerative changes, or increased dura-cortex adhesions.
The hydrogel sealant applied to collagen-based dural grafts significantly reduced CSF leakage and functioned as an adhesion barrier. Such technology could be an important tool for cranial surgery.
作者评估了一种基于聚乙二醇的水凝胶密封剂系统是否能通过基于胶原蛋白的硬脑膜成形术覆盖移植物改善硬脑膜闭合情况。
在12只犬类动物身上制造直径为1.5厘米的硬脑膜缺损,并使用两种市售硬脑膜成形术覆盖产品之一进行修复。在6只动物中,将水凝胶应用于硬脑膜覆盖物上,另外6只动物仅接受硬脑膜成形术。在更换骨瓣之前,评估水密闭合情况。在处死动物之前,重新打开颅骨切开术切口,由对治疗组不知情的神经外科医生对粘连情况进行评分,并使用压力测试评估硬脑膜完整性。
除硬脑膜成形术外还接受水凝胶密封剂的动物在术中能承受高达20厘米水柱的瓦尔萨尔瓦动作而无脑脊液(CSF)漏出。仅接受硬脑膜成形术的动物在自发压力下出现脑脊液漏(p = 0.0022)。术后,所有6只仅接受硬脑膜成形术的犬出现脑脊液皮下积聚,而接受水凝胶应用的犬只有1只(16.7%)出现这种情况(p = 0.0152)。在取材时(植入后8周),仅接受硬脑膜成形术的犬在骨瓣和硬脑膜之间有广泛瘢痕形成(粘连评分中位数为4,范围3 - 4)。接受水凝胶的动物瘢痕形成最少(粘连评分中位数为0.5,范围0 - 2)。在接受水凝胶治疗的犬中,平均粘连评分比仅接受硬脑膜成形术的动物低82.6%(p = 0.0043)。在接受水凝胶的动物中,平均硬脑膜漏压力为56.8±2.5厘米水柱,而仅接受硬脑膜成形术的犬为9.8±3.8厘米水柱(p = 0.0392)。水凝胶的应用与神经毒性、愈合延迟、退行性改变或硬脑膜 - 皮质粘连增加无关。
应用于基于胶原蛋白的硬脑膜移植物的水凝胶密封剂显著减少了脑脊液漏,并起到了粘连屏障的作用。这种技术可能是颅脑手术的重要工具。